Purification of VWF for increased removal of non-lipid enveloped viruses

Invention Grant

US09315560B2 Purification of VWF for increased removal of non-lipid enveloped viruses 有权

Title translation: 纯化VWF以增加去除非脂质包膜病毒

Patent Title: Purification of VWF for increased removal of non-lipid enveloped viruses
Patent Title (中): 纯化VWF以增加去除非脂质包膜病毒
Application No.: US12860501

Application Date: 2010-08-20
Publication No.: US09315560B2

Publication Date: 2016-04-19
Inventor: Artur Mitterer , Meinhard Hasslacher , Christa Mayer
Applicant: Artur Mitterer , Meinhard Hasslacher , Christa Mayer
Applicant Address: US IL Bannockburn CH Glattpark (Opfikon)
Assignee: BAXALTA INCORPORATED,BAXALTA GMBH
Current Assignee: BAXALTA INCORPORATED,BAXALTA GMBH
Current Assignee Address: US IL Bannockburn CH Glattpark (Opfikon)
Agency: Marshall, Gerstein & Borun LLP
Main IPC: C07K14/755
IPC: C07K14/755 ; C07K1/18 ; A61K38/00

Abstract:

The present invention provides methods for purifying Von Willebrand factor (VWF) for increased removal of non-lipid enveloped viruses.

Abstract(Chinese):

本发明提供用于纯化Von Willebrand因子（VWF）用于增加去除非脂质包膜病毒的方法。

Public/Granted literature

Information query

Espacenet

IPC分类:

C	化学；冶金
C07	有机化学
C07K	肽（含有β-内酰胺的肽入C07D；在分子中除了形成本身的肽环外不含有任何其他的肽键的环状二肽，如哌嗪-2,5-二酮入C07D；环肽型麦角生物碱入C07D519/02；单细胞蛋白质、酶入C12N；获得肽的基因工程方法入C12N15/00）
C07K14/00	具有多于20个氨基酸的肽；促胃液素；生长激素释放抑制因子；促黑激素；其衍生物
C07K14/435	.来自动物；来自人类
C07K14/745	..血液凝固或（血）纤维蛋白溶解（作用）因子
C07K14/755	...Ⅷ因子